Sisram Medical Ltd (HKG:1696)
5.81
-0.22 (-3.65%)
Aug 22, 2025, 3:45 PM HKT
Sisram Medical Revenue
Sisram Medical had revenue of $165.48M USD in the half year ending June 30, 2025, a decrease of -3.58%. This brings the company's revenue in the last twelve months to $345.86M, down -2.96% year-over-year. In the year 2024, Sisram Medical had annual revenue of $349.11M, down -2.83%.
Revenue (ttm)
$345.86M
Revenue Growth
-2.96%
P/S Ratio
1.01
Revenue / Employee
$340.75K
Employees
1,015
Market Cap
2.75B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 349.11M | -10.18M | -2.83% |
Dec 31, 2023 | 359.29M | 4.81M | 1.36% |
Dec 31, 2022 | 354.48M | 60.19M | 20.45% |
Dec 31, 2021 | 294.29M | 132.20M | 81.56% |
Dec 31, 2020 | 162.10M | -11.43M | -6.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.99B |
Sisram Medical News
- 3 days ago - Sisram Medical reports 1H results - Seeking Alpha
- 1 year ago - Sirsram Medical announces NMPA approval for DAXXIFY® - Benzinga